Ipamorelin Re-Usable Metal Pen Kit

PRODUCT DESCRIPTION
Peptide Name: Ipamorelin 
 
RESEARCHED AREAS AND BENEFITS
Growth hormone selective release
Lean muscle mass stimulation
Adipose tissue lipolysis reduction
Bone mineral density enhancement
Gastric motility improvement research
 
Chemical Name: (2S)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2S)-2-[(2-amino-2-methylpropanoyl)amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-3-phenylpropanoyl]amino]hexanamide
CAS Number: 170851-70-4
 
DESCRIPTION 
Ipamorelin is a synthetic pentapeptide and a selective agonist of the ghrelin/growth hormone secretagogue receptor. It is recognized in clinical research for its ability to stimulate the anterior pituitary gland to release growth hormone (GH) without significantly affecting other hormones such as cortisol, prolactin, or ACTH. This high level of selectivity distinguishes it from earlier generations of GH-releasing peptides (GHRPs). Originally investigated for its potential in treating postoperative ileus and growth disorders, it is now a primary subject in studies concerning metabolic optimization and age-related physiological decline.
Selective Secretagogue: Research demonstrates it triggers pulsatile GH release, mimicking natural biological rhythms more closely than synthetic HGH.
Metabolic Impact: Studies indicate its role in promoting fat loss and improving muscle protein synthesis through elevated IGF-1 levels.
Skeletal Health: Clinical data in animal models suggests it can counteract bone loss and increase longitudinal bone growth.
Gastric Support: Investigations have explored its efficacy in accelerating gastric emptying and resolving symptoms of postoperative bowel dysfunction.
 
KIT INCLUDES
1x V1 All Metal Reusable Pen
1x Peptide lyophilised Vial
1x 3ml Cartridge
1x Travel Case
1x Recon Kit
20x Alcohol swabs
20x Pen Tips (more pen tips can be bought separately)
 
REGULATORY NOTICES
SAHPRA DISCLAIMER This product has not been evaluated by the South African Health Products Regulatory Authority (SAHPRA). It is not intended to diagnose, treat, cure, or prevent any disease.
RESEARCH USE ONLY
 
SCIENTIFIC STUDIES
Ipamorelin, the first selective growth hormone secretagogue: https://pubmed.ncbi.nlm.nih.gov/9849822/
Ipamorelin induces longitudinal bone growth in rats: https://pubmed.ncbi.nlm.nih.gov/10373343/
Efficacy of the ghrelin mimetic ipamorelin for management of postoperative ileus: https://pubmed.ncbi.nlm.nih.gov/25331030/
Role of growth hormone secretagogues in management of body composition: https://pmc.ncbi.nlm.nih.gov/articles/PMC7108996/